Here are the S-1 registration statements from Helio Corporation (HLEO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow HLEO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLEO filings page.
Helio Corp. (HLEO) is offering 2,000,000 shares of common stock; the total would be 2,300,000 shares if the underwriters exercise the over-allotment option in full. The estimated price is $4.00 to $5.00 per share, with $4.50 as the assumed price. Closing is contingent on approval of its Nasdaq Capital Market listing application. Helio estimates net proceeds of approximately $7.073 million to $8.914 million, assuming no over-allotment, and intends to use them for repayment of certain promissory notes, research and development, sales, marketing and business development, facility and manufacturing improvements, and general and working-capital purposes.
Revenue for the nine months ended July 31, 2026 was $11,543,492, versus $33,384,423 for the same period in 2025, a 54% decline; net loss was $6,851,175. Helio estimates dilution to new investors of $3.84 per share at the assumed $4.50 price. Audit reports expressed substantial doubt about its ability to continue as a going concern, and management concluded its disclosure controls were ineffective as of July 31, 2026 due to material weaknesses in financial reporting.